Matching patients to clinical trials with large language models
2024 · Nature Communications · 170 citations
https://doi.org/10.1038/s41467-024-53081-z
C
Charalampos S. Floudas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
118
Papers
1.9K
Citations
18
h-index
33
i10-index
Charalampos S. Floudas is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Research and Treatments & Immunotherapy and Immune Responses. The author has an h-index of 18, co-authored 101 publications.
ORCID: 0000-0002-0020-237XPapers by this author
worksThe contemporary management of cancers of the sinonasal tract in adults
2022 · CA A Cancer Journal for Clinicians · 113 citations
https://doi.org/10.3322/caac.21752
Identifying genetic interactions associated with late-onset Alzheimer’s disease
2014 · BioData Mining · 22 citations
https://doi.org/10.1186/s13040-014-0035-z
PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer
2025 · Cancer Immunology Immunotherapy · 6 citations
https://doi.org/10.1007/s00262-025-04009-z
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non–Small-Cell Lung Cancer
2024 · JCO Precision Oncology · 2 citations
https://doi.org/10.1200/po.23.00371
Tregs, gMDSCs, and levels of soluble MICA as prognostic biomarkers for combined NEO-201 and pembrolizumab.
2024 · Journal of Clinical Oncology · 2 citations
https://doi.org/10.1200/jco.2024.42.16_suppl.2530
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat